Evidence map›Paper›PMID 38108258›Full record

ArticleJournal of the American Heart Association2023

Hospital-Level Variability in Reporting of Ischemic Stroke Subtypes and Supporting Diagnostic Evaluation in GWTG-Stroke Registry.

Michael T Mullen, M Edip Gurol, Shyam Prabhakaran, Steven R Messé, Dawn O Kleindorfer, Eric E Smith, Gregg C Fonarow, Haolin Xu, Xin Zhao, Joaquin E Cigarroa and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

Michael T MullenTemple University Hospital, Temple University Philadelphia PA.ORCID 0000-0001-8300-7731
M Edip GurolMassachusetts General Hospital Harvard University Boston MA.ORCID 0000-0002-2169-4457
Shyam PrabhakaranUniversity of Chicago Chicago IL.ORCID 0000-0003-0724-1694
Steven R MesséHospital of the University of Pennsylvania The University of Pennsylvania Philadelphia PA.ORCID 0000-0003-3108-5441
Dawn O KleindorferMichigan Medicine University of Michigan Ann Arbor MI.ORCID 0000-0003-1361-3693
Eric E SmithHotchkiss Brain Institute University of Calgary Calgary Alberta Canada.ORCID 0000-0003-3956-1668
Gregg C FonarowRonald Reagan UCLA Medical Center, UCLA Los Angeles CA.ORCID 0000-0002-3192-8093
Haolin XuDuke Clinical Research Institute Durham NC.ORCID 0000-0003-1069-9567
Xin ZhaoDuke Clinical Research Institute Durham NC.
Joaquin E CigarroaOHSU Hospital, Oregan Health and Science University Portland OR.ORCID 0000-0003-1567-6006
Lee H SchwammMassachusetts General Hospital Harvard University Boston MA.ORCID 0000-0003-0592-9145
Clinical Research Institute · USHarvard University · USHospital of the University of Pennsylvania · USMichigan Medicine · USOregon Health and Science University Hospital · USRonald Reagan UCLA Medical Center · USTemple University Hospital · USUniversity of Calgary · CAUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSecondary prevention of ischemic stroke (IS) requires adequate diagnostic evaluation to identify the likely etiologic subtype. We describe hospital-level variability in diagnostic testing and IS subtyping in a large nationwide registry. METHODS AND

resultsWe used the GWTG-Stroke (Get With The Guidelines-Stroke) registry to identify patients hospitalized with a diagnosis of acute IS at 1906 hospitals between January 1, 2016, and September 30, 2017. We compared the documentation rates and presence of risk factors, diagnostic testing, achievement/quality measures, and outcomes between patients with and without reported IS subtype. Recording of diagnostic evaluation was optional in all IS subtypes except cryptogenic, where it was required. Of 607 563 patients with IS, etiologic IS subtype was documented in 57.4% and missing in 42.6%. Both the rate of missing stroke pathogenesis and the proportion of cryptogenic strokes were highly variable across hospitals. Patients missing stroke pathogenesis less frequently had documentation of risk factors, evidence-based interventions, or discharge to home. The reported rates of major diagnostic testing, including echocardiography, carotid and intracranial vascular imaging, and short-term cardiac monitoring were <50% in patients with documented IS pathogenesis, although these variables were missing in >40% of patients. Long-term cardiac rhythm monitoring was rarely reported, even in cryptogenic stroke.

conclusionsReporting of IS etiologic subtype and supporting diagnostic testing was low overall, with high rates of missing optional data. Improvement in the capture of these data elements is needed to identify opportunities for quality improvement in the diagnostic evaluation and secondary prevention of stroke.

Indexed as

Brain IschemiaIschemic StrokeStrokeHospitalsHumansRegistriesTomography, X-Ray Computeddiagnostic testingischemicquality and outcomesstroke

Identifiers

PMID38108258
PMCPMC10863791
OpenAlexW4389884923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.